Clinical Analysis of Simultaneous Pancreas-kidney Transplantation for End-stage Renal Disease Associated With Diabetes Mellitus
NCT05497232 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2022-08-11
Summary
The first pancreas transplantation was performed in 1966, by 2015, more than 40,000 pancreas transplantation have been performed worldwide. Nevertheless, only several Chinese organ transplant centers carry out SPK because of surgery complications. simultaneous pancreas-kidney transplantation is a new and promising therapeutic option for the treatment for type 1 diabetes mellitus patients and end-stage renal disease. the preliminary treatment results are summarized to promote the further development of this work in China.
Conditions
- Diabetes Mellitus;Uremia
Interventions
- PROCEDURE
-
simultaneous pancreas-kidney transplantation
Renal transplants were performed to the right external iliac artery and vein, and the ureter was anastomosed to the recipient ureter by using end-to-end anastomoses techniques. All the renal allografts were placed into retroperitoneum. Enteric drainage of exocrine secretions was performed on all pancreas transplants, systemic venous outflow (postcava), and arterial reconstruction with "y" graft (iliac artery). Lastly in all cases of renal transplant, the artery was anastomosed in all cases. The pancreas was placed intra-abdominally in all cases.
Sponsors & Collaborators
-
Second Affiliated Hospital of Guangzhou Medical University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-01-01
- Completion
- 2024-01-01
Countries
- China
Study Locations
More Related Trials
-
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
NCT05216172 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes
NCT04127084 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of Empagliflozin in NODAT
NCT03642184 ·Status: TERMINATED ·Phase: PHASE4
-
Steroid Diabetes in Patients With Kidney Disease
NCT06161701 ·Status: RECRUITING
-
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
NCT05938712 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
NCT04562025 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
NCT07077538 ·Status: RECRUITING ·Phase: NA
-
Effects of Disease Management on Development of End Stage Renal Disease in Type 2 Diabetic Patients With Nephropathy
NCT00309127 ·Status: COMPLETED ·Phase: NA
-
Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
NCT00253786 ·Status: COMPLETED ·Phase: NA
-
All-encompassing Program Led by Diabetes Specialist Team
NCT03497390 ·Status: COMPLETED ·Phase: NA
-
PeRsOnalising Treatment Of Diabetic Nephropathy:
NCT03509454 ·Status: COMPLETED
-
Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes
NCT06532682 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease
NCT02512068 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
NCT06222476 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
NCT07275788 ·Status: RECRUITING ·Phase: PHASE1
-
Pathogenesis of Kidney Disease in Type 1 Diabetes: a Modern Kidney Biopsy Cohort (The PANDA Study)
NCT05319990 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Empagliflozin vs Linagliptin on Glycemic Outcomes,Renal Outcomes & Body Composition in Renal Transplant Recipients With Diabetes Mellitus
NCT06095492 ·Status: RECRUITING ·Phase: NA
-
PROTOCOL 3: Role of the Renal Nerves in the Increase in EGP in Response to Glucosuria
NCT03168295 ·Status: COMPLETED ·Phase: PHASE4
-
Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients
NCT06483074 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 ·Status: COMPLETED ·Phase: NA
-
Adiponectin and Insulin Resistance in Diabetic Nephropathy
NCT00774904 ·Status: COMPLETED ·Phase: NA
-
Kidney Biopsy Indications in Type 2 Diabetes Patients
NCT04006028 ·Status: COMPLETED
-
The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
NCT06528405 ·Status: RECRUITING ·Phase: PHASE2
-
Empagliflozin in Post-Transplantation Diabetes Mellitus
NCT03113110 ·Status: COMPLETED ·Phase: PHASE2
-
Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)
NCT02176278 ·Status: COMPLETED ·Phase: NA